Value of MS treatments in China 2017-2028
In 2022, the value of multiple sclerosis (MS) treatments performed in China amounted to around 1.3 billion U.S. dollars, representing an increase of more than 400 million dollars from 2017. The figure is estimated to exceed two billion dollars by 2028.